0
0
Read Time:9 Second
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 15, 2025, titled “Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.025%.”. |SUBJECT: Press Release
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
